CVE-2026-34323 Overview
CVE-2026-34323 is an improper access control vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications, specifically affecting the IDM Authentication component. This easily exploitable vulnerability allows an unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm systems. Successful exploitation requires human interaction from a person other than the attacker, making it a social engineering-dependent attack vector.
Critical Impact
Successful exploitation can result in unauthorized update, insert, or delete access to some Oracle Life Sciences InForm accessible data, unauthorized read access to a subset of data, and the ability to cause a partial denial of service (DoS) condition.
Affected Products
- Oracle Life Sciences InForm version 7.0.1.0
- Oracle Life Sciences InForm version 7.0.1.1
Discovery Timeline
- April 21, 2026 - CVE-2026-34323 published to NVD
- April 23, 2026 - Last updated in NVD database
Technical Details for CVE-2026-34323
Vulnerability Analysis
This vulnerability is classified under CWE-284 (Improper Access Control), indicating that the IDM Authentication component fails to properly restrict access to protected resources. The flaw exists in how the authentication mechanism processes HTTP requests, allowing unauthenticated attackers to bypass security controls when a victim user performs specific actions.
The attack requires network access and human interaction, suggesting a scenario where an attacker could craft malicious HTTP requests or links that, when accessed by an authenticated user, could lead to unauthorized data manipulation or disclosure. The triple impact on confidentiality, integrity, and availability indicates the vulnerability affects multiple security domains within the application.
Root Cause
The root cause lies in improper access control implementation within the IDM Authentication component of Oracle Life Sciences InForm. The authentication mechanism does not adequately validate user permissions before processing certain HTTP requests, allowing unauthorized actions to be performed when combined with social engineering techniques that leverage legitimate user sessions.
Attack Vector
The vulnerability is exploitable via network access through HTTP, requiring no prior authentication from the attacker. However, successful exploitation depends on human interaction—specifically, a legitimate user must be tricked into performing an action that triggers the vulnerability. This could involve clicking a malicious link, submitting a crafted form, or interacting with attacker-controlled content while authenticated to the InForm application.
The attack flow typically involves the attacker crafting a specially designed HTTP request and delivering it to the victim through phishing or other social engineering methods. When the victim interacts with the malicious content while authenticated, the improper access controls allow the attacker to read, modify, or delete data, or cause service disruption.
Detection Methods for CVE-2026-34323
Indicators of Compromise
- Unusual HTTP requests to the IDM Authentication component from unexpected sources or with anomalous parameters
- Unauthorized data modifications in Oracle Life Sciences InForm databases that cannot be attributed to legitimate user activity
- Authentication logs showing access patterns indicative of session manipulation or replay attacks
- Reports from users of unexpected application behavior after clicking links or interacting with external content
Detection Strategies
- Implement Web Application Firewall (WAF) rules to detect and block malicious HTTP request patterns targeting the IDM Authentication component
- Monitor authentication logs for anomalous access patterns, particularly requests that bypass normal authentication flows
- Deploy network traffic analysis to identify unusual HTTP traffic directed at Oracle Life Sciences InForm servers
- Configure alerting for unauthorized data access or modification attempts within the InForm application
Monitoring Recommendations
- Enable detailed logging for the IDM Authentication component and regularly review for suspicious activity
- Implement real-time alerting for authentication failures and unusual session behavior
- Monitor database audit logs for unauthorized CRUD operations on sensitive clinical data
- Establish baseline network behavior and alert on deviations in HTTP traffic to InForm servers
How to Mitigate CVE-2026-34323
Immediate Actions Required
- Apply the security patch from Oracle's April 2026 Critical Patch Update immediately for all affected InForm installations
- Restrict network access to Oracle Life Sciences InForm servers to authorized users and networks only
- Implement additional authentication controls such as multi-factor authentication (MFA) for InForm users
- Conduct security awareness training to help users identify and avoid social engineering attempts
Patch Information
Oracle has addressed this vulnerability in the April 2026 Critical Patch Update. Administrators should obtain and apply the patch from the Oracle Security Alert April 2026. The patch corrects the improper access control issue in the IDM Authentication component for Oracle Life Sciences InForm versions 7.0.1.0 and 7.0.1.1.
Workarounds
- Implement network segmentation to isolate Oracle Life Sciences InForm servers from untrusted networks
- Deploy a Web Application Firewall (WAF) with rules specifically configured to protect the IDM Authentication endpoint
- Enable strict Content Security Policy (CSP) headers to reduce the risk of social engineering attacks
- Consider temporarily disabling external access to the InForm application until patches can be applied
# Example: Network isolation configuration for InForm servers
# Restrict HTTP access to InForm to internal networks only
iptables -A INPUT -p tcp --dport 80 -s 10.0.0.0/8 -j ACCEPT
iptables -A INPUT -p tcp --dport 443 -s 10.0.0.0/8 -j ACCEPT
iptables -A INPUT -p tcp --dport 80 -j DROP
iptables -A INPUT -p tcp --dport 443 -j DROP
Disclaimer: This content was generated using AI. While we strive for accuracy, please verify critical information with official sources.

